Research groups

Research Projects Available

Dphil in cardiovascular science

Technology, Artificial Intelligence, and Data Driven Solutions for Cardiovascular and Metabolic Disease

DPhil in medical sciences opportunities will appear below:

MSc by Research in medical sciences opportunities will appear below:

Colleges

Websites

Sky news
Findings from the C-MORE - multiorgan MRI Study
BBC news
Findings from the C-MORE - multiorgan MRI Study
BBC world radio
Betty Raman presenting findings from the C-MORE study (8:20)

Betty Raman

MBBS DPhil FESC FRACP

Associate Professor of Cardiovascular Medicine

NIHR South Central RRDN Cardiology Specialty Lead
Hon. Consultant Cardiologist (Loc)
Oxford Programme Director of BHF Doctoral Training Programme on Technology, Data and AI (Imperial-Oxford DTP)
Wellcome Career Development Award Fellow
RDM Cardiovascular Medicine EDI Champion

Prof Betty Raman is a senior honorary consultant cardiologist specialising in advanced cardiovascular imaging (CMR and cardiac CT) and inherited and cardiomyopathic heart disease. She leads a translational research programme in monogenic (e.g., HCM, DCM etc) and polygenic cardiac (hypertensive heart diseases, cardiometabolic etc.) diseases that bridge mechanistic discovery, clinical application, and innovation in drug development.

After completing her specialist cardiology training in Australia (FRACP), she joined the University of Oxford in 2015 to pursue a DPhil in hypertrophic cardiomyopathy, the leading cause of sudden cardiac death in young adults and athletes. Her doctoral work led to the development of a novel oxygen sensitive magnetic resonance method that detects myocardial hypoxia non-invasively and holds promise as an early biomarker of disease activity. This pioneering work has been recognised internationally through awards from the ESC, AHA, BSCMR, SCMR, and BCS.

Building on this foundation, she was awarded a British Heart Foundation Transition Fellowship (2020) and subsequently a Wellcome Career Development Award (2024) to advance a multidisciplinary research programme integrating imaging, genetics, energetics, and computational modelling. Her goal is to identify and validate early markers of disease progression in hypertrophic (e.g., HCM) and related cardiomyopathies, enabling more precise risk prediction and supporting evaluation of emerging therapies.

During the COVID 19 pandemic, she led the C-MORE study, a large multicentre initiative that combined MRI, cardiopulmonary exercise testing, and cognitive assessments to characterise the long term multi organ consequences of COVID 19. This work helped shape understanding of post-viral cardiovascular and systemic recovery.

Her current research focuses on:

Early stage disease detection and monitoring in cardiomyopathies using next generation CMR including BOLD, DTI, spectroscopy, and radiomics.
Mechanistic biomarkers to support early phase and adaptive clinical trials.
Cross organ interactions in cardiometabolic disease, integrating heart, brain, liver, and renal imaging.

As a senior academic leader, she collaborates widely across academia, the NHS, and industry to translate advanced imaging into clinical and commercial impact. She actively welcomes scientific collaborators, students, and industrial partners interested in biomarker discovery, imaging enabled trial design, and AI based modelling for cardiovascular disease.

Collaborators

Recent publications

Recombinant shingles vaccination and the risk of cardiovascular events.

Corsi-Zuelli F. et al, (2026), Nat Med

Late Gadolinium Enhancement in Nonischemic Dilated Cardiomyopathy.

Raman B. and Prasad SK., (2026), Circulation, 154, 512 - 516

Multi-organ structural and functional deficits in association with long COVID: a population-based case-control study.

Fernández-Sanlés A. et al, (2026), EClinicalMedicine, 98

Trientine for hypertrophic cardiomyopathy: a phase 2 trial.

Farrant JP. et al, (2026), Eur Heart J

Unmasking Supervillin : SVIL haploinsufficiency causes hypertrophic cardiomyopathy by impairing mechanotransduction and cellular energetics

Li YJ. et al, (2026)

Non-invasive pressure-volume loop analysis in left ventricular load manipulation.

Pola K. et al, (2026), Clin Physiol Funct Imaging, 46

Digital twin reconstruction of ventricular repolarisation identifies regional causes of T-wave abnormalities in hypertrophic cardiomyopathy

Coleman JA. et al, (2026)

COVID-19 outcomes and persistent symptoms in patients with hypertrophic cardiomyopathy: association with pre-existing cardiovascular magnetic resonance phenotype.

Singhal A. et al, (2026), Heart

Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry.

HCMR Investigators . et al, (2026), JAMA

Pictorial review: A Step-by-step Guide to Coronary CT Angiography with Photon-Counting Detector CT.

Xie C. et al, (2026), Br J Radiol

Biobank-Scale Plasma Proteomics Identifies Novel Biomarkers in Hypertrophic Cardiomyopathy.

Chan JH. et al, (2026), Circ Genom Precis Med

Investigating prognostic classifications of pre-existing multiple long-term conditions for health outcomes one-year after COVID-19 hospitalisation: a UK prospective observational study.

Gardiner LE. et al, (2026), Int J Infect Dis

Consortium-Based Patient and Public Involvement and Engagement for Long COVID Research: A Pirit-Focused Impact Evaluation of the PHOSP-COVID Study.

Houchen-Wolloff L. et al, (2026), Health Expect, 29

HFpEF and MASLD: converging mechanisms and clinical implications.

Capone F. et al, (2026), Nat Rev Cardiol

Evaluating Acute Ischemic Myocardial Injury With Photon-Counting Computed Tomography.

Kotronias RA. et al, (2026), JACC Cardiovasc Imaging, 19, 284 - 287

Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.

Stewart I. et al, (2026), EBioMedicine, 124

Left Atrial Reservoir Strain Predicts Atrial Fibrillation in Hypertrophic Cardiomyopathy: Insights from the NHLBI HCM Registry.

Beyhoff N. et al, (2026), JACC Cardiovasc Imaging, 19, 133 - 135

Comparison of cardiac diffusion MRI using multiple prospective respiratory motion correction techniques.

Jermy S. et al, (2026), Magn Reson Med, 95, 442 - 456

Sleep apnea at the frontier- an integrated multidisciplinary functional framework.

Beache GM. et al, (2025), Sleep Med Rev, 84

A Review of Multimodality Imaging in Hypertrophic Cardiomyopathy: Diagnosis, Risk Stratification, and Therapeutic Guidance.

Gandhi R. et al, (2025), Radiol Cardiothorac Imaging, 7

Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestry.

Schuermans A. et al, (2025), Nat Cardiovasc Res, 4, 1662 - 1676

Computational modelling of myocardial metabolism in patients with advanced heart failure.

Beyhoff N. et al, (2025), Eur J Heart Fail, 27, 3411 - 3422

Prospective electrocardiographic and cardiovascular magnetic resonance alterations in the UK Biobank coronavirus disease 2019 repeat imaging study.

Chadalavada S. et al, (2025), Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 27

Multi-center investigation of cardiac diffusion tensor imaging in healthy volunteers by the Society of Cardiovascular Magnetic Resonance Cardiac Diffusion Special Interest Group NETwork (SIGNET).

Teh I. et al, (2025), Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 27

Subclinical Postpartum Renal Structure After Hypertensive Pregnancy Disorders.

Cutler HR. et al, (2025), Hypertension, 82, 1948 - 1958

Brain and muscle chemistry in myalgic encephalitis/chronic fatigue syndrome (ME/CFS) and long COVID: a 7T magnetic resonance spectroscopy study.

Godlewska BR. et al, (2025), Mol Psychiatry, 30, 5215 - 5226

The safety, physiological response and repeatability of the incremental shuttle walk test in survivors of COVID-19.

Baldwin MM. et al, (2025), ERJ Open Res, 11

Clinical and cost-effectiveness of diverse posthospitalisation pathways for COVID-19: a UK evaluation using the PHOSP-COVID cohort.

Briggs AH. et al, (2025), BMJ Open Respir Res, 12

Modulating myocardial metabolism in preclinical hypertrophic cardiomyopathy pathogenic variant carriers: a window of opportunity or wishful thinking?

Raman B. and Brociek E., (2025), Cardiovasc Res, 121, 1806 - 1808

Cohort profile: characterisation, determinants, mechanisms and consequences of the long-term effects of COVID-19 - providing the evidence base for health care services (CONVALESCENCE) in the UK.

Jamieson A. et al, (2025), BMJ Open, 15

Assessing the impact of COmorbidities and Sociodemographic factors on Multiorgan Injury following COVID-19: rationale and protocol design of COSMIC, a UK multicentre observational study of COVID-negative controls.

Shergill S. et al, (2025), BMJ Open, 15

Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy.

Tadros R. et al, (2025), Nat Genet, 57, 530 - 538

Demographic-Based Personalized Left Ventricular Hypertrophy Thresholds for Hypertrophic Cardiomyopathy Diagnosis.

Shiwani H. et al, (2025), J Am Coll Cardiol, 85, 685 - 695

Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study.

Tyrer F. et al, (2025), Diabetes Obes Metab, 27, 767 - 776

Multiparametric cardiovascular magnetic resonance evaluation of myocardial perfusion, oxygenation, and energetics in hypertrophic cardiomyopathy following cardiac myosin inhibitor therapy.

Finnigan LEM. et al, (2025), Eur Heart J Cardiovasc Imaging, 26

Myocardial disarray and fibrosis across hypertrophic cardiomyopathy stages associate with ECG markers of arrhythmic risk.

Ashkir Z. et al, (2025), Eur Heart J Cardiovasc Imaging, 26, 218 - 228

Correction to: Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations.

(2025), Brain, 148

Brainstem neurochemical profiles after hospitalisation for COVID-19: a 7T MR spectroscopy study.

Graf C. et al, (2025), Front Neurosci, 19

Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study.

Gharibzadeh S. et al, (2025), EClinicalMedicine, 79

MECHANISMS OF MYALGIC ENCEPHALITIS/CHRONIC FATIGUE SYNDROME (ME/CFS) AND LONG COVID WITH PREDOMINANT FATIGUE: A MAGNETIC RESONANCE SPECTROSCOPY STUDY OF THE BRAIN AND MUSCLE AT 7 TESLA

Godlewska B. et al, (2025), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 28, i60 - i61

Diagnostic utility of electrocardiogram for screening of cardiac injury on cardiac magnetic resonance in post-hospitalised COVID-19 patients: a prospective multicenter study.

Samat AHA. et al, (2024), Int J Cardiol, 415

Clinical Significance of Myocardial Injury in Patients Hospitalized for COVID-19: A Prospective, Multicenter, Cohort Study.

Shiwani H. et al, (2024), JACC Cardiovasc Imaging, 17, 1320 - 1331

Feasibility of multiorgan risk prediction with routinely collected diagnostics: a prospective cohort study in the UK Biobank.

McCracken C. et al, (2024), BMJ Evid Based Med, 29, 313 - 323

Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.

Taquet M. et al, (2024), Lancet Psychiatry, 11, 696 - 708

1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study.

Leavy OC. et al, (2024), ERJ Open Res, 10

Differentiating Left Ventricular Remodeling in Aortic Stenosis From Systemic Hypertension.

Mahmod M. et al, (2024), Circ Cardiovasc Imaging, 17

Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies.

Reddy SA. et al, (2024), Eur Respir J, 64

Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.

Coleman JA. et al, (2024), Cardiovasc Res, 120, 914 - 926

The complexity of cardiovascular long COVID: where we are.

Gandhi RS. and Raman B., (2024), Cardiovasc Res, 120, e30 - e32

Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study - PHOSP-COVID.

Elneima O. et al, (2024), ERJ Open Res, 10

Flow inefficiencies in non-obstructive HCM revealed by kinetic energy and hemodynamic forces on 4D-flow CMR.

Pola K. et al, (2024), Eur Heart J Imaging Methods Pract, 2

Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation study.

Siontis KC. et al, (2024), Eur Heart J Digit Health, 5, 416 - 426

Photon-counting computed tomography: 'one-stop shop' for coronary stenosis, inflammation, and myocardial assessment in ST-segment elevation acute coronary syndrome.

Kotronias RA. et al, (2024), Eur Heart J Cardiovasc Imaging, 25

Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy.

Maron MS. et al, (2024), J Am Coll Cardiol, 83, 2037 - 2048

Long COVID and cardiovascular disease: a prospective cohort study.

Lawson CA. et al, (2024), Open Heart, 11

Personalizing Apical Hypertrophic Cardiomyopathy Diagnosis: A Major Step Forward, but Challenges Remain.

Raman B., (2024), JACC Cardiovasc Imaging, 17, 513 - 515

Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19.

Devine K. et al, (2024), Clin Endocrinol (Oxf), 100, 317 - 327

NHS Health Check attendance is associated with reduced multiorgan disease risk: a matched cohort study in the UK Biobank.

McCracken C. et al, (2024), BMC Med, 22

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.

C-MORE/PHOSP-COVID Collaborative Group ., (2023), Lancet Respir Med, 11, 1003 - 1019

Implementable Deep Learning for Multi-sequence Proton MRI Lung Segmentation: A Multi-center, Multi-vendor, and Multi-disease Study.

Astley JR. et al, (2023), J Magn Reson Imaging, 58, 1030 - 1044

Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis.

Ashkir Z. et al, (2023), Eur Heart J Cardiovasc Imaging, 24, 1192 - 1200

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study.

Jackson C. et al, (2023), Lancet Respir Med, 11, 673 - 684

Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.

Farrant J. et al, (2023), Heart, 109, 1175 - 1182

Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis.

Dawson C. et al, (2023), BMJ Open Respir Res, 10

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls.

Zheng B. et al, (2023), Lancet Reg Health Eur, 29

Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy.

Hermida U. et al, (2023), Eur Heart J Cardiovasc Imaging, 24, 807 - 818

Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.

Hundertmark MJ. et al, (2023), Circulation, 147, 1654 - 1669

Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study.

Finnigan LEM. et al, (2023), EClinicalMedicine, 59

Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study.

McAuley HJC. et al, (2023), EClinicalMedicine, 57

Long COVID: mechanisms, risk factors and recovery.

Astin R. et al, (2023), Exp Physiol, 108, 12 - 27

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.

Liew F. et al, (2023), EBioMedicine, 87

Differentiating left ventricular remodelling in aortic stenosis from systemic hypertension and impact of surgical replacement

Mahmod M. et al, (2023)

Subclinical Flow Inefficiencies in Non-Obstructive Hypertrophic Cardiomyopathy Subgroups Revealed by 4D Flow Cardiovascular Magnetic Resonance

Pola K. et al, (2023), CIRCULATION, 148

Efficacy and Tolerability of AXA1125, an Endogenous Metabolic Modulator Composition, in Fatigue-predominant Long COVID: A Randomized, Double-blind, Placebo-controlled Study

Finnigan L. et al, (2023), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 207

Post-Hospitalisation COVID-19 (PHOSP-COVID): a prospective multi-centre UK cohort study

Elneima O. et al, (2023), EUROPEAN RESPIRATORY JOURNAL, 62

Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization

Taquet M. et al, (2023), NATURE MEDICINE

Myocardial structure and function assessed by cardiac magnetic resonance in adolescents with perinatal-acquired HIV infection taking antiretroviral therapy

Majonga E. et al, (2023), BMJ GLOBAL HEALTH, 8, A7 - A7

IMPAIRED STRESS MYOCARDIAL OXYGENATION PRECEDES CONTRACTILE ABNORMALITIES IN THREE MODELS OF CARDIAC HYPERTROPHY: INSIGHTS FROM A NOVEL OXYGEN SENSITIVE CARDIAC MAGNETIC RESONANCE APPROACH

Akhtar MA. et al, (2023), HEART, 109, A8 - A9

LIVER DISEASE ACTIVITY IS A SIGNIFICANT RISK FACTOR FOR CARDIOVASCULAR OUTCOMES -A PROSPECTIVE ANALYSIS OF 33,616 INDIVIDUALS FROM THE UK BIOBANK

Roca-Fernandez A. et al, (2023), GASTROENTEROLOGY, 164, S72 - S73

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.

PHOSP-COVID Collaborative Group ., (2022), Lancet Respir Med, 10, 761 - 775

Device-assessed sleep and physical activity in individuals recovering from a hospital admission for COVID-19: a multicentre study.

Plekhanova T. et al, (2022), Int J Behav Nutr Phys Act, 19

Associations between moderate alcohol consumption, brain iron, and cognition in UK Biobank participants: Observational and mendelian randomization analyses.

Topiwala A. et al, (2022), PLoS Med, 19

Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19.

Houchen-Wolloff L. et al, (2022), Thorax, 77, 717 - 720

Postpartum blood pressure self-management following hypertensive pregnancy: protocol of the Physician Optimised Post-partum Hypertension Treatment (POP-HT) trial.

Kitt J. et al, (2022), BMJ Open, 12

Long-term clinical outcomes in patients with a working diagnosis of myocardial infarction with non-obstructed coronary arteries (MINOCA) assessed by cardiovascular magnetic resonance imaging.

Ananthakrishna R. et al, (2022), Int J Cardiol, 349, 12 - 17

Comprehensive clinical assessment identifies specific neurocognitive deficits in working-age patients with long-COVID.

Holdsworth DA. et al, (2022), PLoS One, 17

Four-dimensional flow cardiac magnetic resonance assessment of left ventricular diastolic function.

Ashkir Z. et al, (2022), Front Cardiovasc Med, 9

The effects of sleep disturbance on dyspnoea and impaired lung function following COVID-19 hospitalisation: a prospective multi-centre cohort study

Jackson C. et al, (2022)

Cardiopulmonary Assessment of COVID-19 Survivors Stratified by Acute Disease Severity and Post-Acute Symptoms

Szekely Y. et al, (2022), CIRCULATION, 146

Persistence of inflammatory and vascular damage mediators 5 months after acute COVID-19

Petousi N. et al, (2022), EUROPEAN RESPIRATORY JOURNAL, 60

ASSOCIATION OF MRI-DERIVED LIVER BIOMARKERS WITH CARDIOVASCULAR RISK FACTORS, OUTCOMES, AND ALL-CAUSE MORTALITY-A PROSPECTIVE ANALYSIS OF 33,616 INDIVIDUALS FROM THE UK BIOBANK COHORT

Roca-Fernandez A. et al, (2022), HEPATOLOGY, 76, S727 - S728

NOVEL INSIGHTS INTO DIMINISHED CARDIAC RESERVE IN HYPERTROPHIC CARDIOMYOPATHY FROM 4D FLOW CMR COMPONENT ANALYSIS

Ashkir Z. et al, (2022), HEART, 108, A3 - A4

Association Between Sarcomeric Variants in Hypertrophic Cardiomyopathy and Myocardial Oxygenation: Insights From a Novel Oxygen-Sensitive Cardiovascular Magnetic Resonance Approach.

Raman B. et al, (2021), Circulation, 144, 1656 - 1658

Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy: Biomarker Variability and its Impact on Clinical Care.

Captur G. et al, (2021), JACC Cardiovasc Imaging, 14, 2123 - 2134

Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.

Evans RA. et al, (2021), Lancet Respir Med, 9, 1275 - 1287

Symptom Persistence Despite Improvement in Cardiopulmonary Health - Insights from longitudinal CMR, CPET and lung function testing post-COVID-19.

Cassar MP. et al, (2021), EClinicalMedicine, 41

Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study.

Raman B. et al, (2021), J Cardiovasc Magn Reson, 23

Adverse cardiovascular magnetic resonance phenotypes are associated with greater likelihood of incident coronavirus disease 2019: findings from the UK Biobank.

Raisi-Estabragh Z. et al, (2021), Aging Clin Exp Res, 33, 1133 - 1144

Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge.

Raman B. et al, (2021), EClinicalMedicine, 31

Adapting the UK Biobank Brain Imaging Protocol and Analysis Pipeline for the C-MORE Multi-Organ Study of COVID-19 Survivors.

Griffanti L. et al, (2021), Front Neurol, 12

Adapting the UK Biobank brain imaging protocol and analysis pipeline for the C-MORE multi-organ study of COVID-19 survivors

Griffanti L. et al, (2021)

HEALTHIER CMR PHENOTYPES ARE LINKED TO FAVOURABLE BRAIN MRI STRUCTURE AND FUNCTION METRICS IN THE UK BIOBANK

McCracken C. et al, (2021), HEART, 107, A4 - A5

Longitudinal trajectory of cardiac magnetic resonance and cardiopulmonary exercise testing findings in moderate to severe COVID-19 and association with symptoms

Cassar MP. et al, (2021), EUROPEAN HEART JOURNAL, 42, 238 - 238

Late Breaking Abstract - Breathlessness post COVID-19 despite improvement in cardiopulmonary health

Cassar MP. et al, (2021), EUROPEAN RESPIRATORY JOURNAL, 58

Magnetic resonance imaging

HESS A. et al, (2020)

Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge

Raman B. et al, (2020)

Myocardial Deformation Analysis in Hypertrophic Cardiomyopathy With Sarcomere Mutations: Insights From 2,221 Patients Within the NHLBI-HCM Registry

Heydari B. et al, (2020), CIRCULATION, 142

Measuring inorganic phosphate and intracellular pH in the healthy and hypertrophic cardiomyopathy hearts by in vivo 7T 31P-cardiovascular magnetic resonance spectroscopy.

Valkovič L. et al, (2019), J Cardiovasc Magn Reson, 21

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications.

Raman B. et al, (2019), Eur Heart J Cardiovasc Imaging, 20, 157 - 167

REAPPRAISING REMODELLING PATTERN OF LEFT VENTRICLE IN AORTIC STENOSIS: AXIS ORIENTATION AS A UNIQUE SIGNATURE OF POSITIVE REMODELLING

Chan K. et al, (2019), HEART, 105, A18 - A18

STRESS MYOCARDIAL OXYGENATION AND NOT PERFUSION RESERVE DETERMINES ARRHYTHMIC RISK IN HYPERTROPHIC CARDIOMYOPATHY: INSIGHTS FROM A NOVEL OXYGEN-SENSITIVE CMR APPROACH

Raman B. et al, (2019), HEART, 105, A183 - A183

IMPAIRED STRESS-INDUCED OXYGENATION IN HYPERTROPHIC CARDIOMYOPATHY IS ASSOCIATED WITH AN INCREASED RISK OF VENTRICULAR ARRHYTHMIA

Raman B. et al, (2019), HEART, 105, A18 - A20

Impaired Stress Myocardial Oxygenation and Not Perfusion Reserve is Associated With Arrhythmic Risk in Hypertrophic Cardiomyopathy: Insights From a Novel Oxygen Sensitive Cardiac Magnetic Resonance Approach

Raman B. et al, (2019), CIRCULATION, 140

Blunted stress myocardial oxygenation and not myocardial perfusion reserve is associated with arrhythmic risk in hypertrophic cardiomyopathy

Raman B. et al, (2019), EUROPEAN HEART JOURNAL, 40, 1360 - 1360

The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study.

Mahmod M. et al, (2018), J Cardiovasc Magn Reson, 20

Patients with heart failure with mid-range and reduced left ventricular ejection fraction show similar derangement of cardiac energy and lipid metabolism

Mahmod M. et al, (2018), EUROPEAN HEART JOURNAL, 39, 378 - 378

DIFFUSION TENSOR MAGNETIC RESONANCE IMAGING OF MYOCARDIAL DISARRAY IN HYPERTROPHIC CARDIOMYOPATHY

Ariga R. et al, (2018), HEART, 104, A8 - A8

Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]).

Pasupathy S. et al, (2017), Circulation, 136, 894 - 903

Novel Insights into Complex Cardiovascular Pathologies using 4D Flow Analysis by Cardiovascular Magnetic Resonance Imaging.

Lewandowski AJ. et al, (2017), Curr Pharm Des, 23, 3262 - 3267

Adenosine stress CMR T1 mapping detects impaired perfusion and inducible myocardial ischaemia without gadolinium contrast or ionizing radiation in hypertrophic cardiomyopathy

Raman B. et al, (2017), EUROPEAN HEART JOURNAL, 38, 1069 - 1069

Development of Therapeutic Strategies for Takotsubo Syndrome: Insights From a Rat Model

Surikow SY. et al, (2017), CIRCULATION, 136

ADENOSINE STRESS T1 MAPPING: A NOVEL CONTRAST FREE METHOD TO ASSESS MYOCARDIAL PERFUSION AND ISCHAEMIA IN HYPERTROPHIC CARDIOMYOPATHY

Raman B. et al, (2017), HEART, 103, A8 - A9

Can Myocardial Ischaemia in Hypertrophic Cardiomyopathy be Assessed Non-invasively Without Radiation or Contrast Agents?: Role of Novel Adenosine Stress CMR T1 Mapping

Raman B. et al, (2017), Heart, Lung and Circulation, 26, S248 - S248

Troponin-positive chest pain with unobstructed coronary arteries: incremental diagnostic value of cardiovascular magnetic resonance imaging.

Pathik B. et al, (2016), Eur Heart J Cardiovasc Imaging, 17, 1146 - 1152

Cookies on this website